Anticholinergic Medications and Dementia

Angie Szumlinski Health, Studies

An estimated 47 million people worldwide were living with dementia in 2015, while in the United States, around 5.7 million people have Alzheimer’s dementia. Modifiable risk factors, including hypertension, hearing loss, depression, diabetes, and smoking, account for around 35% of dementia cases. Anticholinergic drugs are another potentially modifiable risk factor. This broad group of drugs acts by blocking the neurotransmitter …

Dementia – COVID-19 – Risk

Angie Szumlinski Health, Studies

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and rapidly escalated into a global pandemic. Severe illness of COVID-19 predominantly occurs in older people and in individuals with underlying medical comorbidities. Dementia, including Alzheimer’s disease (AD) is a common cause of morbidity and mortality in the aging population. The majority of people living with …